NEUROLOGIE PRO PRAXI / Neurol. praxi. 2024;25(3):198-202 / www.neurologiepropraxi.cz 202 HLAVNÍ TÉMA Nově vzniklý refrakterní status epilepticus 8. Hirsch LJ, Gaspard N, van Baalen A, et al. Proposed con‑ sensus definitions for new‑onset refractory status epilep‑ ticus (NORSE), febrile infection‑related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018;59(4):739-744. doi: 10.1111/epi.14016. 9. Hirsch LJ, Gaspard N. Status epilepticus. Continuum (Minneap Minn). 2013;19(3 Epilepsy):767-94. doi: 10.1212/01. CON.0000431395.16229.5a. 10. Iizuka T, Kanazawa N, et al. Cryptogenic NORSE: Its distin‑ ctive clinical features and response to immunotherapy. Neurol Neuroimmunol Neuroinflamm. 2017;4(6):e396. doi: 10.1212/ NXI.0000000000000396. 11. Kessi M, Liu F, Zhan Y, et al. Efficacy of different treatment modalities for acute and chronic phases of the febrile infection ‑related epilepsy syndrome: A systematic review. Seizure. 2020;79:61-68. doi: 10.1016/j.seizure.2020. 04. 015. 12. Körtvelyessy P, Lerche H, Weber Y. FIRES and NORSE are distinct entities. Epilepsia. 2012;53(7):1276. doi: 10.1111/j. 1528-1167.2012.03517.x. 13. Kramer U, Chi CS, Lin KL, et al. Febrile infection‑related epi‑ lepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia. 2011;52(11):1956-65. doi: 10.1111/j.1528-1167.2011.03250.x. 14. Luo T, Wang Y, Lu G, et al. Vagus nerve stimulation for super ‑refractory status epilepticus in febrile infection‑related epi‑ lepsy syndrome: a pediatric case report and literature re‑ view. Childs Nerv Syst. 2022 Jul;38(7):1401-1404. doi: 10.1007/ s00381-021-05410-6. 15. Meletti S, Slonkova J, Mareckova I, et al. Claustrum da‑ mage and refractory status epilepticus following febri‑ le illness. Neurology. 2015;85(14):1224-32. doi: 10.1212/ WNL.0000000000001996. 16. Meletti S, Giovannini G, d‘Orsi G, et al. New‑Onset Refracto‑ ry Status Epilepticus with Claustrum Damage: Definition of the Clinical and Neuroimaging Features. Front Neurol. 2017;8:111. doi: 10.3389/fneur.2017.00111. 17. Mikaeloff Y, Jambaqué I, Hertz‑Pannier L, et al. Devastating epileptic encephalopathy in school‑aged children (DESC): a pseudo encephalitis. Epilepsy Res. 2006;69(1):67-79. doi: 10.1016/j.eplepsyres.2006. 01. 002. 18. Nabbout R, Vezzani A, Dulac O, Chiron C. Acute ence‑ phalopathy with inflammation‑mediated status epilep‑ ticus. Lancet Neurol. 2011;10(1):99-108. doi: 10.1016/S14744422(10)70214-3. 19. Nabbout R. FIRES and IHHE: Delineation of the syndro‑ mes. Epilepsia. 2013;54(Suppl. 6):54-6. doi: 10.1111/epi.12278. 20. Sakuma H, Tanuma N, Kuki I, et al. Intrathecal overprodu‑ ction of proinflammatory cytokines and chemokines in febri‑ le infection‑related refractory status epilepticus. J Neurol Neurosurg Psychiatry. 2015;86(7):820-2. doi: 10.1136/jnnp-2014-309388. 21. Sato Y, Numata‑Uematsu Y, Uematsu M, et al. Acute ence‑ phalitis with refractory, repetitive partial seizures: Patholo‑ gical findings and a new therapeutic approach using ta‑ crolimus. Brain Dev. 2016;38(8):772-6. doi: 10.1016/j.brain‑ dev.2016. 02. 006. 22. Sculier C, Gaspard N. New onset refractory status epilepticus (NORSE). Seizure. 2019;68:72-78. doi: 10.1016/j.seizure.2018. 09. 018. 23. Sutter R, Marsch S, Fuhr P, et al. Anesthetic drugs in sta‑ tus epilepticus: risk or rescue? A 6-year cohort study. Neurology. 2014;82(8):656-64. doi: 10.1212/WNL.0000000000000009. 24. Thakur KT, Probasco JC, Hocker SE, et al. Ketoge‑ nic diet for adults in super‑refractory status epi‑ lepticus. Neurology. 2014;82(8):665-70. doi: 10.1212/ WNL.0000000000000151. 25. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long‑term outcome in patients with anti‑NMDA receptor encephalitis: an observational co‑ hort study. Lancet Neurol. 2013;12(2):157-65. doi: 10.1016/S14744422(12)70310-1. 26. Trinka E, Leitinger M. Management of Status Epilepticus, Refractory Status Epilepticus, and Super‑refractory Status Epi‑ lepticus. Continuum (Minneap Minn). 2022;28(2):559-602. doi: 10.1212/CON.0000000000001103. 27. van Baalen A, Vezzani A, Häusler M, et al. Febrile Infection ‑Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis. Neuropediatrics. 2017;48(1):5-18. doi: 10.1055/ s-0036-1597271. 28. Wickstrom R, Taraschenko O, Dilena R, et al; International NORSE Consensus Group. International consensus recommen‑ dations for management of New Onset Refractory Status Epi‑ lepticus (NORSE) incl. Febrile Infection‑Related Epilepsy Syn‑ drome (FIRES): Statements and Supporting Evidence. Epilepsia. 2022;63(11):2840–64. doi: 10.1111/epi.17397. 29. Wilder‑Smith EP, Lim EC, Teoh HL, et al. The NORSE (new ‑onset refractory status epilepticus) syndrome: defining a di‑ sease entity. Ann Acad Med Singap. 2005;34(7):417-20. 30. Yamazoe T, Okanishi T, Yamamoto A, et al. New‑onset refractory status epilepticus treated with vagus nerve sti‑ mulation: A case report. Seizure. 2017;47:1-4. doi: 10.1016/j. seizure.2017. 02. 011. PŘEDNÁŠKY Indukční léčba RS, včasné nasazení vysoce účinné terapie MUDr. Marta Vachová Co se děje při imunorekonstituci – nové detailní poznatky MUDr. Veronika Tichá, Ph.D. MR v prognóze a monitoraci aktivity u RS pacientů prof. MUDr. Manuela Vaněčková, Ph.D. Kdy je čas na imunorekonstituční léčbu? – MUDr. Marta Vachová TOS – anatomie, klinika, diferenciální diagnostika – MUDr. Tomáš Bauer TOS – klinické vyšetření, EMG, konzervativní léčba MUDr. Štěpánka Brušáková, MBA ZLATÝ PARTNER POČET KREDITŮ 2 Registrace ZDARMA TERMÍN prosinec 2023 až listopad 2024 dostupný na online.solen.cz On-line kurz pro praktické neurology 2 2023 ON LINE KURZ ODBORNÝ GARANT: MUDr. Marta Vachová POŘADATEL: SOLEN, s. r. o., ve spolupráci s Neurologickým oddělením s RS centrem, Nemocnice Teplice, o. z. – Krajská zdravotní, a. s., Teplice.
RkJQdWJsaXNoZXIy NDA4Mjc=